Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer
about
Are another 5 years of adjuvant aromatase inhibitor therapy needed?Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance.Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival.Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.Rutin Isolated from Chrozophora tinctoria Enhances Bone Cell Proliferation and Ossification Markers.
P2860
Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Pharmacologic management of bo ...... eceptor-positive breast cancer
@ast
Pharmacologic management of bo ...... eceptor-positive breast cancer
@en
Pharmacologic management of bo ...... eceptor-positive breast cancer
@nl
type
label
Pharmacologic management of bo ...... eceptor-positive breast cancer
@ast
Pharmacologic management of bo ...... eceptor-positive breast cancer
@en
Pharmacologic management of bo ...... eceptor-positive breast cancer
@nl
prefLabel
Pharmacologic management of bo ...... eceptor-positive breast cancer
@ast
Pharmacologic management of bo ...... eceptor-positive breast cancer
@en
Pharmacologic management of bo ...... eceptor-positive breast cancer
@nl
P2860
P3181
P356
P1476
Pharmacologic management of bo ...... eceptor-positive breast cancer
@en
P2093
Denise A Yardley
P2860
P3181
P356
10.2147/BCTT.S97963
P407
P577
2016-01-01T00:00:00Z